SSKN STRATA Skin Sciences, Inc.

Price Chart

Executive Summary

STRATA Skin Sciences, Inc. (SSKN) has filed Form 15-12G to terminate the registration of its Common Stock under Section 12(g) of the Securities Exchange Act of 1934, effectively deregistering the stock and ceasing its public reporting obligations. The company cites Rule 12g-4(a)(1), indicating it has fewer than 300 holders of record — the reported number is 157 — which allows it to deregister voluntarily. This 'going dark' move reduces transparency and liquidity for shareholders.

Actionable Insight

Key Facts

• STRATA Skin Sciences, Inc. (SSKN) filed Form 15-12G to terminate registration of its Common Stock under Section 12(g) of the Exchange Act.
• The filing was submitted on March 2, 2026, and is effective immediately.
• Approximate number of holders of record: 157, qualifying the company for deregistration under Rule 12g-4(a)(1).
• The company is no longer required to file periodic reports (e.g., 10-K, 10-Q) with the SEC.
• SSKN is currently traded on the OTC market, where it will likely remain, but with reduced disclosure and oversight.
• No acquisition or merger is indicated as the reason for deregistration — this appears to be a cost-saving or strategic decision due to low shareholder count.

Financial Impact

Non-quantifiable direct financial impact, but significant reduction in regulatory and reporting costs for the company. Shareholders lose access to audited financials and real-time disclosures.

Risk Factors

• Decreased transparency increases information asymmetry, favoring insiders over public shareholders.
• Potential decline in trading volume and liquidity on the OTC market post-deregistration.
• Difficulty in valuation due to lack of future SEC filings like 10-Ks and 10-Qs.

Market Snapshot

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

US Market Status